In an op-ed for MarketWatch, Brett Arens’s Roi warns about rising Medicare Part D premiums. The...
Drugs and technology
Will the administration step in to curb prices on drugs...
For more than 30 years, the federal government has failed to rely on the Bayh-Dole Act to reduce...
If you use an inhaler, your out-of-pocket costs should come down...
As of Saturday June 8, many people in the US will pay $35 a month out of pocket for their asthma...
FTC cleaning up junk patents on 20 brand-name drugs
Pharmaceutical companies don’t only get to set their prices on brand-name drugs, they can...
CVS profits from manufacturing its own generic drugs
CVS has become the sixth largest corporation in America, owning not only a chain of pharmacies, but...
Will insulin ever be affordable in the US?
The pharmaceutical industry is all too powerful in the US. Not only does it spend a lot of money...
Medicare Part D drug coverage stunts are rampant
When it comes to Medicare Part D prescription drug coverage, one thing’s for sure: Medicare...
Will FDA approval of Wegovy to treat heart conditions mean more...
The FDA recently approved Wegovy, a weight-loss drug, to treat overweight people with heart...
Some Democrats oppose Biden’s goal of lowering more Medicare...
The Lever reports on a cadre of Democratic Congressmen committed to opposing Biden’s goal of...
Billions in Medicare savings from Medicare drug price...
A new report from Nicole Rapfogel at the Center for American Progress (CAP) finds that the...